August 16, 2018

Evolution In EGFRM+ Lung Cancer

Interest in the EGFR Lung cancer space initially started with the isolation of Epidermal growth factor (EGF) gene by Stanley Cohen in 1962 as a protein extracted from the mouse submaxillary gland that accelerated incisor eruption. Therefore, it was originally termed ‘tooth-lid factor’, but was later renamed EGF because it stimulated the proliferation of epithelial cells. Since then substantial progress has been made against lung cancer over the last two decades. Research has also powered the emergence of new targeted treatments which are helping patients live a longer and higher quality life after a lung cancer diagnosis. This infographic allows the reader to dwell deeper and look closely into the history of discovery, evolution and advancements pertaining to EGFR lung cancer space.
July 17, 2018
top 20 pharmaceutical brands (2017 sales)

Top 20 Pharmaceutical Brands

An overview of the top 20 pharmaceutical products/brands based on sales of 2017.
July 10, 2018
Immunotherapy Biomarkers

Immunotherapy Biomarkers

Cancer immunotherapy has provided substantial clinical benefit in a significant number of patients with advanced disease. However, the need for more precise immunotherapies and predictive biomarkers remains pressing. This infographics contains a timeline on immunotherapy related biomarkers developed so far.
July 10, 2018

Top 20 pharma companies of 2018

An overview of the top 20 global pharmaceutical companies of 2018, with a quick glance into the top 10.
June 4, 2018
major milestone

Major Milestones in Cancer Research

Research and development within the cancer field is continuously evolving and progressing. This infographic highlights the biggest milestones within the field of cancer research spanning 170 years —from the advent of general anesthesia opening the door for cancer surgery in the mid-1800s to the first gene therapy for cancer approved by the Food and Drug Administration in 2017.
February 13, 2018
Pharma Sickness 2030

Sickness 2030

A brief overview of the major mortality drivers in 2030 by age and gender